[go: up one dir, main page]

SG11201602256UA - Production method for diazabicyclooctane derivative and intermediary body thereof - Google Patents

Production method for diazabicyclooctane derivative and intermediary body thereof

Info

Publication number
SG11201602256UA
SG11201602256UA SG11201602256UA SG11201602256UA SG11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA
Authority
SG
Singapore
Prior art keywords
production method
intermediary body
diazabicyclooctane derivative
diazabicyclooctane
derivative
Prior art date
Application number
SG11201602256UA
Other languages
English (en)
Inventor
Takao Abe
Takeshi Furuuchi
Yoshiaki Sakamaki
Nakako Mitsuhashi
Original Assignee
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Pharma Co Ltd filed Critical Meiji Seika Pharma Co Ltd
Publication of SG11201602256UA publication Critical patent/SG11201602256UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SG11201602256UA 2013-09-24 2014-09-24 Production method for diazabicyclooctane derivative and intermediary body thereof SG11201602256UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013197110 2013-09-24
PCT/JP2014/075203 WO2015046207A1 (ja) 2013-09-24 2014-09-24 ジアザビシクロオクタン誘導体の製造法とその中間体

Publications (1)

Publication Number Publication Date
SG11201602256UA true SG11201602256UA (en) 2016-04-28

Family

ID=52743343

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602256UA SG11201602256UA (en) 2013-09-24 2014-09-24 Production method for diazabicyclooctane derivative and intermediary body thereof

Country Status (22)

Country Link
US (2) US10000491B2 (es)
EP (1) EP3050883B1 (es)
JP (1) JP6453222B2 (es)
KR (1) KR102239725B1 (es)
CN (2) CN107501264A (es)
AR (5) AR097744A1 (es)
AU (1) AU2014324302B2 (es)
BR (1) BR112016006246B8 (es)
CA (1) CA2924953C (es)
DK (1) DK3050883T3 (es)
ES (1) ES2793201T3 (es)
HK (2) HK1219473A1 (es)
HU (1) HUE049027T2 (es)
IL (1) IL244740B (es)
MX (2) MX367578B (es)
MY (2) MY176278A (es)
NZ (1) NZ718009A (es)
RU (1) RU2719480C2 (es)
SG (1) SG11201602256UA (es)
TW (1) TWI644908B (es)
WO (1) WO2015046207A1 (es)
ZA (1) ZA201602053B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2857401T3 (pl) 2012-05-30 2020-02-28 Meiji Seika Pharma Co., Ltd. NOWY INHIBITOR ß–LAKTAMAZY I SPOSÓB JEGO WYTWARZANIA
CN107501264A (zh) 2013-09-24 2017-12-22 明治制果药业株式会社 二氮杂二环辛烷衍生物的制备方法
SG11201602723RA (en) * 2013-10-08 2016-05-30 Meiji Seika Pharma Co Ltd Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative
EP3228620B1 (en) 2014-12-05 2020-09-02 Meiji Seika Pharma Co., Ltd. Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
CA2944306C (en) 2015-10-30 2023-11-14 The Toronto-Dominion Bank Validating encrypted data from a multi-layer token
US11216808B2 (en) 2015-11-04 2022-01-04 The Toronto-Dominion Bank Token-based system for excising data from databases
JP2020011901A (ja) * 2016-10-20 2020-01-23 協和キリン株式会社 ピロリジン化合物の製造方法
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
US10584123B2 (en) 2017-09-27 2020-03-10 Fedora Pharmaceuticals Inc. Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof
JP7179058B2 (ja) 2017-09-27 2022-11-28 Meiji Seikaファルマ株式会社 ジアザビシクロオクタン誘導体の剤形およびその生産プロセス
US10759800B2 (en) 2017-09-27 2020-09-01 Fedora Pharmaceuticals Inc. Crystalline forms of diazabicyclooctane derivatives and production process thereof
CN109678856B (zh) * 2017-10-18 2020-09-25 新发药业有限公司 一种阿维巴坦中间体的制备方法
JP7289836B2 (ja) 2017-11-23 2023-06-12 エフ. ホフマン-ラ ロシュ アーゲー プロリンヒドロキシラーゼ、ならびにそれに伴う使用、方法および生成物
WO2020018462A1 (en) 2018-07-16 2020-01-23 Brown University A chromogenic beta-lactamase substrate
US11897844B2 (en) * 2018-09-21 2024-02-13 Api Corporation Method for producing amino acid derivatives
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
WO2021038403A1 (en) 2019-08-30 2021-03-04 DePuy Synthes Products, Inc. Electrical device for monitoring, prevention, and treatment of implant infections

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038509B1 (es) 1970-10-21 1975-12-10
JPS538509A (en) 1976-07-13 1978-01-26 Toshiba Corp Impedance matching system for data transmission circuit
JPS6019759B2 (ja) 1977-11-24 1985-05-17 イ−ライ・リリ−・アンド・カンパニ− 非経口投予用11115152139199東京都中央区京橋2丁目3番13号
GB1589317A (en) 1977-11-24 1981-05-13 Lilly Co Eli Freeze drying cephalothin sodium
JPS60255723A (ja) 1984-05-31 1985-12-17 Ono Pharmaceut Co Ltd メシル酸ガベキサートの結晶性凍結乾燥製剤及びその製造方法
JPH07117533B2 (ja) 1985-08-28 1995-12-18 株式会社生体科学研究所 トランスフエリンおよびその用途
US20030220521A1 (en) 1989-07-27 2003-11-27 G.D. Searle & Co. Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension
TW264475B (es) 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
PL179435B1 (pl) * 1993-12-29 2000-09-29 Pfizer Diazabicykliczni antagonisci neurokininy PL
JP2843444B2 (ja) 1994-05-02 1999-01-06 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の結晶,該結晶を含む凍結乾燥製剤,およびその製造方法
AU700545B2 (en) 1994-05-02 1999-01-07 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2815420B1 (fr) 2000-10-16 2003-05-16 Cit Alcatel Compensation de la dispersion chromatique dans un systeme de transmission a fibre optique, et fibre de compensation
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2921060B1 (fr) 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
UA101966C2 (en) 2008-01-18 2013-05-27 Мерк Шарп Енд Доме Корп. Beta-lactamase inhibitors
FR2930553B1 (fr) 2008-04-29 2010-05-21 Novexel Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
FR2936798B1 (fr) 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
US20120053350A1 (en) 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
FR2951171A1 (fr) 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
JP2012122603A (ja) 2010-11-15 2012-06-28 Nifco Inc コネクタ装置
SI2657234T1 (sl) * 2010-12-22 2017-06-30 Meiji Seika Pharma Co., Ltd. Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
CA2780403C (en) 2011-06-17 2020-04-21 Forest Laboratories Holdings Ltd. Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
ES2603198T3 (es) 2011-08-27 2017-02-24 Wockhardt Limited Derivados de 1,6-diazabiciclo [3,2,1]octan-7-ona y su uso en el tratamiento de infecciones bacterianas
BR112013032974A2 (pt) 2011-08-30 2016-09-06 Wockhardt Ltd "derivados de 1,6-diazabiciclo [3,2,1]-octan-7-ona, seus usos, e composições farmacêuticas".
AU2012310136B2 (en) 2011-09-13 2016-07-07 Wockhardt Limited Nitrogen containing compounds and their use
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
PL2857401T3 (pl) 2012-05-30 2020-02-28 Meiji Seika Pharma Co., Ltd. NOWY INHIBITOR ß–LAKTAMAZY I SPOSÓB JEGO WYTWARZANIA
CN107501264A (zh) 2013-09-24 2017-12-22 明治制果药业株式会社 二氮杂二环辛烷衍生物的制备方法
SG11201602723RA (en) * 2013-10-08 2016-05-30 Meiji Seika Pharma Co Ltd Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative

Also Published As

Publication number Publication date
US20160264573A1 (en) 2016-09-15
AR097744A1 (es) 2016-04-13
CN105555787B (zh) 2017-08-08
BR112016006246B1 (pt) 2021-09-08
EP3050883B1 (en) 2020-04-22
ES2793201T3 (es) 2020-11-13
US20170283415A1 (en) 2017-10-05
AU2014324302B2 (en) 2018-02-15
JP6453222B2 (ja) 2019-01-16
BR112016006246A2 (es) 2017-08-22
CA2924953A1 (en) 2015-04-02
EP3050883A1 (en) 2016-08-03
DK3050883T3 (da) 2020-05-25
US10000492B2 (en) 2018-06-19
RU2016115767A (ru) 2017-10-26
MY193210A (en) 2022-09-26
AR131186A2 (es) 2025-02-26
US10000491B2 (en) 2018-06-19
MX372585B (es) 2020-04-17
IL244740A0 (en) 2016-04-21
RU2016115767A3 (es) 2018-06-29
CA2924953C (en) 2021-12-07
TW201546059A (zh) 2015-12-16
BR112016006246B8 (pt) 2021-10-05
HK1244487A1 (zh) 2018-08-10
HUE049027T2 (hu) 2020-08-28
MX367578B (es) 2019-08-27
AR131188A2 (es) 2025-02-26
JPWO2015046207A1 (ja) 2017-03-09
AU2014324302A1 (en) 2016-05-12
KR102239725B1 (ko) 2021-04-12
HK1219473A1 (zh) 2017-04-07
MY176278A (en) 2020-07-27
AR131190A2 (es) 2025-02-26
TWI644908B (zh) 2018-12-21
EP3050883A4 (en) 2017-05-10
CN107501264A (zh) 2017-12-22
CN105555787A (zh) 2016-05-04
RU2719480C2 (ru) 2020-04-17
MX2016003867A (es) 2016-08-04
KR20160058851A (ko) 2016-05-25
NZ718009A (en) 2018-03-23
IL244740B (en) 2018-11-29
AR131189A2 (es) 2025-02-26
WO2015046207A1 (ja) 2015-04-02
ZA201602053B (en) 2019-06-26

Similar Documents

Publication Publication Date Title
HK1219473A1 (zh) 二氮雜二環辛烷衍生物的製備方法及其中間體
EP2987649A4 (en) TIRES AND METHOD FOR THE PRODUCTION OF TIRES
EP3006415B8 (en) Method for producing nanocement and nanocement
HK1219479A1 (zh) 二氮雜二環辛烷衍生物的結晶及其製備方法
EP2987650A4 (en) TIRE AND METHOD FOR PRODUCING THE SAME
GB201401248D0 (en) Method of manufacture
PL2991817T3 (pl) Sposób dopasowywania i sposób wytwarzania dla elementów konstrukcyjnych wytwarzanych za pomocą SLM
EP2990072A4 (en) METHOD OF MANUFACTURING NEEDLE-BODY BODIES
SI3043814T1 (sl) Antigen in postopek za proizvodnjo le-tega
IL242191B (en) Moving body system and mdrive method of moving body
AP2016009136A0 (en) A method for the treatment of metals
EP3010699A4 (en) Method for manufacturing structural body and manufacturing apparatus therefor
GB201305231D0 (en) Method of Manufacture
IL241096A0 (en) Treatment methods
IL245749B (en) An n-phenyldiacrylimide derivative containing bromine is a method for its preparation
EP3045442A4 (en) Method for producing cyclolavandulol and derivative thereof
GB201312588D0 (en) Vehicle and method of control thereof
EP3045443A4 (en) Method for producing -cyclolavandulal and derivative of same
PL3041506T3 (pl) Sposób leczenia
GB2515780B (en) Cremation process and apparatus
GB201319281D0 (en) Bed and method of manufacture thereof
GB201300367D0 (en) Method of calibrating neural asynchronies
EP2957649A4 (en) SLIDING ELEMENT AND PRODUCTION METHOD FOR SLIDING ELEMENT
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment